TROYA Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
TROYA Therapeutics revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Key Contacts at TROYA Therapeutics
Viktor Techen Lemgart
Director Of Research
Jan Johannes Enghild
Co-Founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
TROYA Therapeutics Email Formats
TROYA Therapeutics uses 1 email format. The most common is {first name} (e.g., john@troya-tx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@troya-tx.com | 100% |
About TROYA Therapeutics
At TROYA, we use protein engineering to control the activity of medicines, improving their potency and safety.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
Director
Founder/Owner
Employees by Department
TROYA Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
TROYA Therapeutics has never raised funding before.
Australia
United States
United Kingdom
ItalyFrequently asked questions
TROYA Therapeutics is located in XX.
TROYA Therapeutics generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.
TROYA Therapeutics has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
TROYA Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
